Follow
Jiechuang Su
Jiechuang Su
Postdoctoral Research Fellow, BC Cancer Agency Research Center, Vancouver
Verified email at bccrc.ca - Homepage
Title
Cited by
Cited by
Year
Diflavin oxidoreductases activate the bioreductive prodrug PR-104A under hypoxia
CP Guise, MR Abbattista, SR Tipparaju, NK Lambie, J Su, D Li, ...
Molecular pharmacology 81 (1), 31-40, 2012
772012
The 2-nitroimidazole EF5 is a biomarker for oxidoreductases that activate the bioreductive prodrug CEN-209 under hypoxia
J Wang, A Foehrenbacher, J Su, R Patel, MP Hay, KO Hicks, WR Wilson
Clinical Cancer Research 18 (6), 1684-1695, 2012
732012
Dual targeting of hypoxia and homologous recombination repair dysfunction in triple-negative breast cancer
FW Hunter, HL Hsu, J Su, SM Pullen, WR Wilson, J Wang
Molecular cancer therapeutics 13 (11), 2501-2514, 2014
502014
Zinc finger nuclease knock-out of NADPH: cytochrome P450 oxidoreductase (POR) in human tumor cell lines demonstrates that hypoxia-activated prodrugs differ in POR dependence
J Su, Y Gu, FB Pruijn, JB Smaill, AV Patterson, CP Guise, WR Wilson
Journal of Biological Chemistry 288 (52), 37138-37153, 2013
292013
FSL-61 is a 6-nitroquinolone fluorogenic probe for one-electron reductases in hypoxic cells
J Su, CP Guise, WR Wilson
Biochemical Journal 452 (1), 79-86, 2013
272013
Zinc finger nuclease mediated knockout of ADP-dependent glucokinase in cancer cell lines: effects on cell survival and mitochondrial oxidative metabolism
S Richter, S Morrison, T Connor, J Su, CG Print, RS Ronimus, SL Mcgee, ...
PLoS One 8 (6), e65267, 2013
182013
Print, CG, Ronimus, RS, McGee, SL and Wilson, WR (2013) Zinc finger nuclease mediated knockout of ADP-dependent glucokinase in cancer cell lines: effects on cell survival and …
S Richter, S Morrison, T Connor, J Su
PLoS One 8 (6), e65267, 0
11
EF5 as a predictive biomarker for activation of the new hypoxia-targeting prodrug SN30000.
J Wang, A Foehrenbacher, J Su, R Patel, MP Hay, KO Hicks, WR Wilson, ...
Journal of Clinical Oncology 29 (15_suppl), e13597-e13597, 2011
52011
Identification of human oxidoreductases involved in the hypoxia-dependent activation of bioreductive prodrugs
CP Guise, SR Tipparaju, MR Abbattista, GU Dachs, J Su, ...
Cancer Research 70 (8_Supplement), 453-453, 2010
12010
Dissecting the role of NADPH: cytochrome P450 oxidoreductase in the activation of hypoxia-activated prodrugs using zinc finger nucleases
J Su
PhD Thesis-University of Auckland, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–10